<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03726073</url>
  </required_header>
  <id_info>
    <org_study_id>XJH-A-20181001</org_study_id>
    <nct_id>NCT03726073</nct_id>
  </id_info>
  <brief_title>Acupoint Stimulation Improve Postoperative Delirium in Elderly Patients</brief_title>
  <acronym>AICE</acronym>
  <official_title>Effect of Transcutaneous Acupoint Electrical Acupoint Stimulation Combined With Auricular Acupressure on Postoperative Delirium in Elderly Patients Undergoing Major Abdominal Surgery: a Pragmatic Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Force Military Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Air Force Military Medical University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative delirium is with increased incidence in elderly patients. Previous studies have&#xD;
      shown that acupuncture related techniques could induce protection against brain ischemia and&#xD;
      improve outcome after cerebral diseases. In this study the effect of transcutaneous&#xD;
      electrical acupoint stimulation combined with auricular acupressure on postoperative delirium&#xD;
      will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative delirium (POD) is an acute neurological disorder that commonly happens between&#xD;
      postoperative days 1 and 3 and more common reported in elderly patients. The rate of delirium&#xD;
      differs depending on the patients' characteristics, surgery types and setting of health care.&#xD;
      The prevalence of delirium range from 18% to 35 % in a general medical service, and up to&#xD;
      half of older patients postoperatively. It has been documented that POD is associated with an&#xD;
      increase in mortality and morbidity, increased use of hospital resources, and higher cost of&#xD;
      health care. The conventional preventive methods for delirium have focused on minimization or&#xD;
      elimination of the predisposing and precipitating factors. Yet, few effective therapies are&#xD;
      available for treating POD. New treatments are needed to reduce the prevalence and severity&#xD;
      of delirium.&#xD;
&#xD;
      Complementary therapies, particularly acupuncture, have gained increasing attention for their&#xD;
      possible value in the prevention and treatment of neurological disorders. Both basic and&#xD;
      clinical studies have suggested that acupuncture may be beneficial to postoperative delirium.&#xD;
      In functional MRI studies of healthy subjects and nervous system dysfunction patients,&#xD;
      acupuncture has been shown to stimulate hippocampus, amygdala and insula, areas of the brain&#xD;
      associated with memory, cognition and emotion.&#xD;
&#xD;
      In the clinical, TEAS has been reported to be effective in alleviating delirium in elderly&#xD;
      patients with silent lacunar infarction. Evidence also showed that auricular acupunctures are&#xD;
      efficacious for preventing postoperative agitation in geriatric patients&#xD;
&#xD;
      Given evidences of the possible efficacy of TEAS and auricular acupressure, we aim to do a&#xD;
      2-arm, randomized, controlled, single-blinded, pragmatic trial to investigate whether&#xD;
      transcutaneous electrical acupoint stimulation combined with auricular acupressure is more&#xD;
      effective in reducing postoperative delirium in elderly patients than usual care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 17, 2019</start_date>
  <completion_date type="Anticipated">December 10, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
    <masking_description>transcutaneous electrical acupoint stimulation and auricular acupressure is given by an investigator who is not involved in anesthesia and outcome assessment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of delirium</measure>
    <time_frame>From the end of surgery to 7 days after surgery</time_frame>
    <description>In postoperative 7 days or during patients stay in hospital if discharged within 7 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The severity of delirium</measure>
    <time_frame>From the end of surgery to 7 days after surgery or during patients stay in hospital if discharged within 7 days</time_frame>
    <description>Assessed by memorial delirium assessment scale (MDAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>24h, 48h, 72h after surgery</time_frame>
    <description>Postoperative pain both at rest and with movement using Numeric Rating Scale (NRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>S100B level</measure>
    <time_frame>Before surgery and at the end of the surgery</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuron-specific enolase level</measure>
    <time_frame>Before surgery and at the end of the surgery</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain-derived neurotrophic factor level</measure>
    <time_frame>Before surgery and at the end of the surgery</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor necrosis factor-α level</measure>
    <time_frame>Before surgery and at the end of the surgery</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin- 6 level</measure>
    <time_frame>Before surgery and at the end of the surgery</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aquaporin-4 level</measure>
    <time_frame>Before surgery and at the end of the surgery</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative sleep qualiy</measure>
    <time_frame>4 days after surgery</time_frame>
    <description>Sleep quality within postoperative 4 days using Pittsburgh sleep quality index (PSQI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in hospital after sugery</measure>
    <time_frame>From the day of suregry to discharge from surgery</time_frame>
    <description>Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-10 level</measure>
    <time_frame>Before surgery and at the end of the surgery</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Matrix metalloproteinase 9 level</measure>
    <time_frame>Before surgery and at the end of the surgery</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tau protain level</measure>
    <time_frame>Before surgery and at the end of the surgery</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>β-Amyloid1-42 level</measure>
    <time_frame>Before surgery and at the end of the surgery</time_frame>
    <description>Serum</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Postoperative Complications</condition>
  <condition>Postoperative Delirium</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electrical stimulation will be given 30min before anesthesia and during surgery, auricular acupressure will be given in postoperative 3 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-intervention group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous acupoint electrical acupoint stimulation(TEAS) and auricular acupressure</intervention_name>
    <description>Bilaterally Hegu (LI4), Neiguan (PC6) and Zusanli (ST36) will be used as the TEAS acupoints. Six acupoints (Shenmen, Point Zero, subcortex, heart, liver, and endocrine) located on ears will be used as the auricular acupressure points.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Patients in this group only receive usual care developed by the study hospital</description>
    <arm_group_label>Non-intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled for elective abdominal surgery under general anesthesia&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) physical status class≤Ⅲ;&#xD;
&#xD;
          -  Mini mental state examination (MMSE) score&gt;20;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Implantation of a cardiac pacemaker, cardioverter, defibrillator or internal hearing&#xD;
             aids;&#xD;
&#xD;
          -  Documented alcohol or substance abuse within 3 months before surgery;&#xD;
&#xD;
          -  Dermatological conditions or frail skin;&#xD;
&#xD;
          -  Dysesthesia or infection over the acupoint stimulation skin area;&#xD;
&#xD;
          -  Limb abnormalities;&#xD;
&#xD;
          -  Allergy to ECG pads;&#xD;
&#xD;
          -  Use of psychoactive medications;&#xD;
&#xD;
          -  Severe visual or auditory impairment;&#xD;
&#xD;
          -  Preoperative history of schizophrenia, epilepsy, parkinsonism, depression, or&#xD;
             myasthenia gravis;&#xD;
&#xD;
          -  Brain injury or neurosurgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhihong Lu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xijing Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhihong Lu</last_name>
    <phone>8613891975018</phone>
    <phone_ext>8613891975018</phone_ext>
    <email>deerlu23@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hailong Dong</last_name>
    <phone>8684775337</phone>
    <phone_ext>8613891975018</phone_ext>
    <email>hldong6@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhihong Lu</last_name>
      <phone>8613891975018</phone>
      <phone_ext>8613891975018</phone_ext>
      <email>deerlu23@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Qianqian Fan</last_name>
      <phone>8618092268598</phone>
      <phone_ext>8618092268598</phone_ext>
      <email>qianqianfan0656@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Gao F, Zhang Q, Li Y, Tai Y, Xin X, Wang X, Wang Q. Transcutaneous electrical acupoint stimulation for prevention of postoperative delirium in geriatric patients with silent lacunar infarction: a preliminary study. Clin Interv Aging. 2018 Oct 24;13:2127-2134. doi: 10.2147/CIA.S183698. eCollection 2018.</citation>
    <PMID>30425466</PMID>
  </reference>
  <reference>
    <citation>Arai YC, Ito A, Hibino S, Niwa S, Ueda W. Auricular Acupunctures are Effective for the Prevention of Postoperative Agitation in Old Patients. Evid Based Complement Alternat Med. 2010 Sep;7(3):383-6. doi: 10.1093/ecam/nep172. Epub 2009 Oct 29.</citation>
    <PMID>19875431</PMID>
  </reference>
  <reference>
    <citation>Scholz AF, Oldroyd C, McCarthy K, Quinn TJ, Hewitt J. Systematic review and meta-analysis of risk factors for postoperative delirium among older patients undergoing gastrointestinal surgery. Br J Surg. 2016 Jan;103(2):e21-8. doi: 10.1002/bjs.10062. Epub 2015 Dec 16. Review.</citation>
    <PMID>26676760</PMID>
  </reference>
  <reference>
    <citation>Matsumoto-Miyazaki J, Ushikoshi H, Miyata S, Miyazaki N, Nawa T, Okada H, Ojio S, Ogura S, Minatoguchi S. Acupuncture and Traditional Herbal Medicine Therapy Prevent Deliriumin Patients with Cardiovascular Disease in Intensive Care Units. Am J Chin Med. 2017;45(2):255-268. doi: 10.1142/S0192415X17500161. Epub 2017 Feb 23.</citation>
    <PMID>28231740</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 28, 2018</study_first_submitted>
  <study_first_submitted_qc>October 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2018</study_first_posted>
  <last_update_submitted>September 26, 2020</last_update_submitted>
  <last_update_submitted_qc>September 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Air Force Military Medical University, China</investigator_affiliation>
    <investigator_full_name>Zhihong LU</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <keyword>Delirium</keyword>
  <keyword>Elderly patients</keyword>
  <keyword>Transcutaneous acupoint electrical acupoint stimulation</keyword>
  <keyword>Auricular acupressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data of the study will be available for sharing after publishing, including data of the outcomes</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>The data of the study will be available for sharing after publishing on peer-reviewed journals, and will be available for 5 years</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

